These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 8608977)
21. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204 [TBL] [Abstract][Full Text] [Related]
22. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191 [TBL] [Abstract][Full Text] [Related]
23. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Komiya A; Suzuki H; Ueda T; Yatani R; Emi M; Ito H; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):245-53. PubMed ID: 8946206 [TBL] [Abstract][Full Text] [Related]
24. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Dahiya R; Lee C; McCarville J; Hu W; Kaur G; Deng G Int J Cancer; 1997 Sep; 72(5):762-7. PubMed ID: 9311591 [TBL] [Abstract][Full Text] [Related]
25. Loss of the chromosomal region 10q23-25 in prostate cancer. Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509 [TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of proximal 6q deletions in prostate cancer. Cooney KA; Wetzel JC; Consolino CM; Wojno KJ Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584 [TBL] [Abstract][Full Text] [Related]
28. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517 [TBL] [Abstract][Full Text] [Related]
29. Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies. Neville PJ; Conti DV; Krumroy LM; Catalona WJ; Suarez BK; Witte JS; Casey G Genes Chromosomes Cancer; 2003 Apr; 36(4):332-9. PubMed ID: 12619157 [TBL] [Abstract][Full Text] [Related]
30. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419 [TBL] [Abstract][Full Text] [Related]
31. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer. Lu T; Hano H Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855 [TBL] [Abstract][Full Text] [Related]
32. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322 [TBL] [Abstract][Full Text] [Related]
34. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839 [TBL] [Abstract][Full Text] [Related]
35. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412 [TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246 [TBL] [Abstract][Full Text] [Related]
37. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Qian J; Jenkins RB; Bostwick DG Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062 [TBL] [Abstract][Full Text] [Related]
38. Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer. Crundwell MC; Chughtai S; Knowles M; Takle L; Luscombe M; Neoptolemos JP; Morton DG; Phillips SM Int J Cancer; 1996 Aug; 69(4):295-300. PubMed ID: 8797871 [TBL] [Abstract][Full Text] [Related]
39. Loss of chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers. Brothman AR; Steele MR; Williams BJ; Jones E; Odelberg S; Albertsen HM; Jorde LB; Rohr LR; Stephenson RA Genes Chromosomes Cancer; 1995 Aug; 13(4):278-84. PubMed ID: 7547636 [TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Ittmann MM Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]